A new way of manipulating human pancreatic beta cells appears to mitigate the shortage of donor cells for transplantation to treat type 1 diabetes and the difficulty of expanding differentiated cells in vitro.
Read More »Night-time Hemodialysis Improves Heart Disease in Patients with ESRD
Patients may have a greater capacity to repair their hearts and blood vessels compared to those on conventional dialysis three times a week.
Read More »Mom’s Stress May Trigger Diabetes-Related Autoimmunity in Children
Mothers’ psychological stress, measured as exposure to negative life events, seems to be involved in the onset or progression of diabetes-related beta-cell destruction in young children.
Read More »Women Who Live Alone Face Higher Diabetes Risk
Women who live alone may tend to be more socially isolated, which could in turn affect their lifestyle habits.
Read More »New Under-Skin Glucose Sensor
A prototype under-skin glucose sensor, developed by a Penn State researcher. The glucose biosensor, when placed under the skin, could provide glucose levels for diabetics without a finger prick. The device, which measures about a centimeter by half a centimeter and is about the depth of a thin hair, is …
Read More »Human Insulin Producing Cells Are Regenerated
Transition Therapeutics Inc. announced that a study demonstrating E1-I.N.T.(TM) can stimulate the regeneration of human islet cells.
Read More »New Test Predicts Damage from Diabetes
New test has the potential to be as significant to health care as measuring cholesterol levels.
Read More »Pedometers Increase Activity for Patients Seen at a Family Medicine Clinic
Average individual improvement was 41% over the study period.
Read More »Nerve Changes from Diabetes Begin Earlier Than Previously Known
Mayo Clinic researchers have found that subtle change in nerve conduction is the first reliable sign of nerve complications from diabetes and that this change can be measured long before other symptoms or signs of nerve damage develop.Study Clarifies Insulin’s
Read More »Metformin Safer Than Sulfonylureas in Patients With Diabetes and Heart Failure
Studies showed that mono therapy of metformin had 85% fewer deaths and hospitalizations then sulfonylurea.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.